Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
Cell-permeable peptide inhibitors of the JNK signal transduction pathway for use in the treatment of inflammatory eye diseases.

No-Receipt date 2018-03248 - 17/09/2018
No-Filing date 20180402602 - 17/09/2018
No-Granting date 3097036 - 15/10/2018
No-EPO application date 14004427.2 - 14/10/2011
No-EPO granting date 2902035 - 20/06/2018
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 10/2018 - 25/01/2019
Expiration date 15/10/2031
Kind of title Validation of European Patent
Legal status NOT VALID
Priorities WOPCT/EP2010/00628414/10/2010/WO
WOPCT/EP2011/00030725/01/2011/WO
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61P 27/02
A61K 38/04
A61K 38/03
A61K 38/00

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
913603 XIGEN INFLAMMATION LTD. ARCH. MAKARIOU III 195 NEOCLEOUS HOUSE3030 LIMASSOL CYPRUS

Inventors
CodeFirstnameSurname
2276825 COMBETTE, JEAN-MARC
2276826 DELOCHE, CATHERINE
2276827 ABADIE, CLAIRE

Representatives
CodeFirstnameSurnameAddressTownZip
3177CHARIKLEIAIKALONAROU "TSIMIKALIS KALONAROU DIKIGORIKI ETAIREIA"N. VAMVA 1ATHINA106 74

Contact
CodeFirstnameSurnameAddressTownZipCountry
8126STEFANOS ALEXIOSTSIMIKALISNEOFYTOU VAMVA 1ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments
DateOperationDescreption
5/6/2020 12:00:00 AMΈκπτωση Κύριων Τίτλων (79602) ΕΚΠΤΩΣΕΙΣ 04/2020 Αρ. Πρωτ. ΓΔ 786 / 06-05-2020

Payments history 8 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015